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ABSTRACT Unraveling the conformation of membrane-bound viral fusion peptides is essential for understanding how those
peptides destabilize the bilayer topology of lipids that is important for virus-cell membrane fusion. Here, molecular dynamics
(MD) simulations were performed to investigate the conformation of the 20 amino acids long fusion peptide of inﬂuenza
hemagglutinin of strain X31 bound to a dimyristoyl phosphatidylcholine (DMPC) bilayer. The simulations revealed that the
peptide adopts a kinked conformation, in agreement with the NMR structures of a related peptide in detergent micelles. The
peptide is located at the amphipathic interface between the headgroups and hydrocarbon chains of the lipid by an energetically
favorable arrangement: The hydrophobic side chains of the peptides are embedded into the hydrophobic region and the
hydrophilic side chains are in the headgroup region. The N-terminus of the peptide is localized close to the amphipathic
interface. The molecular dynamics simulations also revealed that the peptide affects the surrounding bilayer structure. The
average hydrophobic thickness of the lipid phase close to the N-terminus is reduced in comparison with the average
hydrophobic thickness of a pure dimyristoyl phosphatidylcholine bilayer.
INTRODUCTION
Membrane fusion between enveloped viruses and host cell
membranes is an obligatory process of viral infection
mediated by viral glycoproteins, e.g., by inﬂuenza virus
hemagglutinin (HA) (Wilson et al., 1981) and by gp41 of
HIV1 (Chan et al., 1997). HA is one of the best-studied viral
proteins mediating fusion (for a review see Skehel and
Wiley, 2000). This protein organizes as a homotrimer. Each
monomer consists of two subunits (polypeptides): HA1 and
the membrane spanning HA2. The potential of HA for
mediating fusion is activated by acidic pH (for a review see
Wiley and Skehel, 1987). Such an activation is accompanied
by a formation of an extended, trimeric coiled-coil structure
of the HA2 subunits (Carr and Kim, 1993; Bullough et al.,
1994; for a review see Eckert and Kim, 2001). This
conformational transition enables the ﬁrst 20 amino acids
of the HA2 N-terminal region, the so-called ‘‘fusion
peptide’’, to bind to and to insert into target cell membrane
(Durrer et al., 1996; Harter et al., 1989; Stegmann et al.,
1991; Tsurudome et al., 1992). Many studies have shown
that the interaction of the HA fusion peptide with the target
membrane is an important factor for membrane fusion (for
a review see Epand, 2003). To understand the role of this
peptide in membrane fusion, it is essential to understand how
the fusion peptide organizes in a membrane and how it
affects the bilayer structure.
Large efforts have been made to determine the structure
of the HA fusion peptide in membranes. A theoretical analy-
sis showed a distinct pattern of hydrophobicity along the
peptide, suggesting that the peptide adopts a predominantly
a-helical conformation upon its binding to the membrane,
with a speciﬁc tilted orientation with respect to the horizontal
membrane plane (Efremov et al., 1999). This has been
experimentally supported for various native and synthetic
viral fusion peptides by various approaches including
electron paramagnetic resonance (EPR), circular dichroism
(CD), attenuated total reﬂection-Fourier transform infrared
(ATR-FTIR), NMR, and neutron diffraction (Bradshaw et al.,
2000; Chang et al., 1997, 2000; Dubovskii et al., 2000;
Lu¨neberg et al., 1995; Macosko et al., 1997). Low-resolution
studies have suggested that the membrane-bound peptide
adopts a rod-like, regular a-helix conformation tilted with
respect to the membrane plane by ;45 (Lu¨neberg et al.,
1995) or 25 (Macosko et al., 1997). However, it is difﬁcult
to determine the high-resolution structure of the membrane-
bound peptide at the atomic level, due to the strong tendency
of the peptide to aggregate in solution as well as in
membranes. Recently, Han and Tamm (2000) linked the HA
fusion peptide of strain X31 (20 amino acids: GLFGA-
IAGFI-ENGWE-GMIDG) to a polar peptide (seven amino
acids: -GCGKKKK) to prevent aggregation. Using this
synthetic peptide P20H7, Han et al. (2001) successfully
determined the structure of the ﬁrst 20 amino acids (i.e., HA
fusion peptide) in detergent micelles of dodecylphosphocho-
line (DPC) by NMR. They showed that these 20 amino acids
fold into a V-shaped structure, forming a hydrophobic
pocket on the side of the peptide oriented to the hydrophobic
region of micelles. Based on secondary structure measure-
ments by CD, Han et al. (2001) concluded that the
conformation of P20H7 bound to a phospholipid bilayer is
very similar to that in DPC micelles.
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To understand the precise role of the fusion peptide in
membrane fusion, it is also necessary to consider the effects
of the embedded peptide on the structure of lipid bilayer. For
example, the peptide may affect the topology and dynamics
of lipids surrounding the peptide. Indeed, a change of the
order parameter of lipid acyl chains (Han et al., 1999), an
increase of intrinsic negative membrane curvature (Epand,
1998), and phase transitions from lamellar to nonlamellar
structures (Colotto and Epand, 1997; Siegel and Epand,
2000) have been reported in the presence of the fusion
peptide. It remains a challenge for experimental approaches
to provide structural information of the peptide-surrounding
lipids. As a complementary approach to experiments, molec-
ular dynamics (MD) simulation may provide such infor-
mation. MD simulation has been applied recently to study
the interaction of peptides with lipid bilayers (e.g., see
Belohorcova et al., 2000; Sankararamakrishnan and
Weinstein, 2000). Kamath and Wong (2002) have reported
a 1.4-ns MD simulation study on the membrane structure of
the human immunodeﬁciency virus gp41 fusion domain in
a 1-palmitoyl-2-oleoylphosphatidylethanolamine (POPE)
bilayer.
The purpose of this study was to investigate the bilayer-
bound conformation of the HA fusion peptide and the im-
pact of the peptide on the structure of the bilayer by MD
simulations. We performed simulations for the fusion
peptide of HA (strain X31) in a dimyristoyl phosphatidyl-
choline (DMPC) bilayer. To examine the effect of the
protonation state of the N-terminus, we simulated two
protonation states of the peptide: one with an unprotonated
N-terminus and another with a protonated N-terminus.
Important structural features of the peptides and the bilayer
were analyzed based on MD simulation trajectories.
METHODS
Sequences of the fusion peptide
We examined the 20 amino acids long fusion peptide of HA X31 strain
(GLFGA-IAGFI-ENGWE-GMIDG) in two different protonation states of
the N-terminus. The peptide with an unprotonated N-terminus is referred to
as peptide I, whereas that with a protonated N-terminus as peptide II. Except
for the N-terminus (Zhou et al., 2000), we are not aware of any study
presenting deﬁnite data about the protonation states of other residues of the
peptide (i.e., Glu-11, Glu-15, and Asp-19). Therefore, we assumed that these
three residues are unprotonated reﬂecting the typical protonation state at
neutral pH.
Initial structures of the simulated systems
The CHARMM program (Brooks et al., 1983) was used to construct two
peptide-bilayer systems for MD simulations (systems I and II). Peptides I
and II were placed in systems I and II, respectively. All hydrogen topology
and parameter ﬁles were taken from MacKerell et al. (1998).
System I was built up with a similar procedure developed by Woolf and
Roux (1994, 1996). The initial conformation and orientation of peptide I in
the DMPC bilayer (Fig. 1 A) was adopted as a rod-like regular a-helix
according to the low-resolution data of CD and electron paramagnetic
resonance studies (Lu¨neberg et al., 1995; Macosko et al., 1997). The central
plane of the bilayer system was deﬁned as the xy plane at z ¼ 0 (Fig. 1 A).
The helical peptide was placed at a position in which its center of mass
(COM) was ;5 A˚ above the central plane. The helical axis was tilted by an
angle of 35 with respect to the central plane. This angle corresponds to the
average of the values of 45 and 25 obtained by Lu¨neberg et al. (1995) and
Macosko et al. (1997), respectively. The projection of the helical axis in the
plane was along the x axis. The N-terminus was orientated toward the
central plane (Fig. 1 A).
The initial size of the simulation box was determined by the number of
DMPC molecules, the cross section area of DMPC molecule, and the
number of hydrated water molecules of the bilayer. The average cross
section area of a single DMPC of 59.8 A˚2 observed at 30C (Petrache et al.,
1998) was taken. To surround the peptide completely, 60 DMPC molecules
were placed in the peptide-harboring leaﬂet (designated as top leaﬂet) of the
bilayer. The DMPC number of the bottom leaﬂet was chosen to match the
area of the top leaﬂet. The projection area of the peptide in the xy plane was
;360 A˚2 corresponding to the cross section area of about six DMPCs. Thus,
the number of DMPCs in the bottom leaﬂet was set to 66. As a consequence,
all eight sides of the unit cell in x- and y-directions were 62.8 A˚ in length.
FIGURE 1 The initial structure of system I. (A) Side view. (B) Top view.
The backbone of the peptide is in green, the hydrophobic side chains in blue,
and the hydrophilic side chains in red. The lipids are drawn as orange lines
except for the N (cyan sphere), P (tan sphere), and carbonyl C (gray sphere)
atoms. Water molecules are indicated as iceblue spheres (not shown in B).
For clarity of the peptide, some lipids and water molecule in A are removed.
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The initial positions of DMPC molecules were determined by the
following procedure. Keeping the peptide rigid, van der Waals (vdW)
spheres representing DMPC lipids were placed to determine the initial
positions of DMPC phosphates in both leaﬂets. The z coordinates of the
phosphate groups of the top and bottom leaﬂets are 117 and 17 A˚,
respectively. Subsequently, the vdW spheres were substituted by DMPC
molecules. The conformation of each DMPC molecule was selected
randomly from a set of 2000 preequilibrated DMPC lipids (Venable et al.,
1993; Woolf and Roux, 1994). By systematical rotation and translation,
unfavorable contacts between heavy atoms within a distance of 2.6 A˚ were
avoided. To get a fully hydrated bilayer, ;4800 preequilibrated water
molecules were placed on the top and bottom regions of the bilayer. The
water molecules were restricted to the DMPC headgroup region forming the
hydration layers, and then the height of the unit cell was set to 72 A˚. Thus,
the dimension of the unit cell was 62.8 A˚ 3 62.8 A˚ 3 72 A˚. The whole
system contained ;30,000 atoms.
We constructed the initial conﬁguration of system II from system I.
Except for the additional proton at the N-terminus (Gly-1), the initial
coordinates of atoms of system II were obtained from system I after a 1-ns
NVE simulation (for details see below). To generate peptide II, a proton was
added to the nitrogen at the N-terminus of peptide I to form anNH13 group
with standard angles and bond lengths.
Initial simulations
To release the starting system, a Langevin dynamics run was ﬁrst carried out.
The system was coupled to a heat bath of 303 K. In a 125-ps run, atomic
constraints were employed by using the following procedure: i), First, the
backbone of the peptide was ﬁxed, the center of mass of each DMPC was
restrained, and the penetration of water was prevented by harmonic forces;
ii), next, harmonic forces were used to restrain the peptide, whereas those
forces to lipids and water were reduced; and iii), subsequently, the restraints
on the peptide were released gradually. Following the Langevin dynamics,
NVE (constant number of particles, volume, and energy) simulations were
performed for ;1.5 ns (1.4 ns for system I and 1.5 ns for system II).
The simulations at this stage were carried with CHARMM program using
the mentioned all-atom force ﬁelds and TIP3 water model (Jorgensen et al.,
1983). In the simulations, periodic rectangular boundary conditions were
applied, and the time step was 2 fs. The SHAKE algorithm was employed to
ﬁx all the lengths of bonds involving hydrogen atoms. Electrostatic and vdW
interactions were cut off above 12 A˚.
NPT simulations
Starting with the conﬁgurations obtained by the initial all-atom NVE
simulations at ;1.5 ns (see above), we switched to united-atom force ﬁelds
to speed up the simulations. To this end, we used the program package
GROMACS (Berendsen et al., 1995; Lindahl et al., 2001). The forced ﬁelds
for peptide were GROMACS force ﬁelds and those for lipids were taken
from Berger et al. (1997). The SPC model was used for water molecules
(Berendsen et al., 1981).
The simulations were performed employing an NPT ensemble (i.e.,
constant number of particles, pressure, and temperature) with a time step of
2 fs. The simulated pressure was P ¼ 1 bar, and the temperature T ¼ 303 K.
Anisotropic pressure-coupling (Berendsen et al., 1984) in x-, y-, and
z-directions was used so that the area per lipid was allowed to adjust during
the simulations. The Berendsen temperature coupling was used with
a coupling constant of 0.1 ps. All bond lengths were constrained by LINCS
algorithm (Hess et al., 1997). The cutoff for vdW interactions was 10 A˚. The
electrostatic interactions were calculated using the particle mesh Ewald
method (Darden et al., 1993; Essmann et al., 1995): The cutoff for real-space
interactions was 10 A˚, and reciprocal-space interactions were evaluated on
a 1.2-A˚ grid with fourth-order spline interpolation. Atomic coordinates of
the simulated systems were saved every 2 ps for analysis. Molecular
graphics were produced by the program VMD (Humphrey et al., 1996).
RESULTS AND DISCUSSION
Equilibration properties
In the initial phase of NVE simulations, we observed
a signiﬁcant change in the backbone conformations of
peptides I and II adopting a kinked shape structure (see
below). However, no further signiﬁcant changes of the
backbone conformations occurred for t. 400 ps. Compared
with the conformation at t ¼ 400 ps of the NVE simulations,
the mean value of root-mean-square deviations (RMSD) of
heavy atoms of the backbone of peptide I was 1.9 6 0.40 A˚
(average of the time interval from 0.4 to1.4 ns) and that of
peptide II, 2.0 6 0.49 A˚ (average of the time interval from
0.4 to 1.5 ns).
Startingwith the conﬁgurations obtained by the initial NVE
simulations at ;1.5 ns, we performed NPT simulations for
a period of 18 ns for both systems. To illustrate the
organization of the peptides in a DMPC bilayer, snapshots
of the simulations are shown in Fig. 2. Snapshots at t ¼ 0 ns
correspond to those of the initial NVE simulations at;1.5 ns
(see Methods). In the NPT simulations, the average area per
lipid is a characteristic parameter for monitoring the equili-
bration process of the systems. The time evolution of the area
per lipid is shown in Fig. 3. For both systems, the area per lipid
ﬂuctuates slightly about the experimental value of 59.8 A˚2
(Petrache et al., 1998) for t. 11 ns. The average value of the
period from 11 to18 ns is 60.06 0.6 A˚2 and 60.16 0.5 A˚2 for
systems I and II, respectively. These values are in very good
agreement with the experimental value. Therefore, both
systems can be considered to be in equilibrium for t. 11 ns.
The time evolution of the secondary structure of the bilayer-
bound peptide also supports that the systems were equili-
brated (see below). Therefore, all related average properties of
the systems presented in the following subsections were
calculated based on the MD trajectories from 11 to 18 ns.
Note that the simulation period needed for equilibrating
a peptide-bilayer system depends largely on the choice of the
initial conformation of the peptide. Because of limited
computational capacity, most of MD studies on peptide-
bilayer systems to date usually are simulations covering
a period from several to tens of nanoseconds. One may
wonder whether this timescale is sufﬁcient for equilibration.
As pointed out by Petrache et al. (2000), if the equilibrium
conformation of the peptide is close to the initial conforma-
tion, MD trajectories may sample an equilibrium population
of states in the vicinity of the initial conformation. In our
systems, the initial conformation of the peptides was not
chosen randomly. The starting a-helical conformation of
peptide I was suggested as the bilayer-bound conforma-
tion of the fusion peptide by low-resolution experiments
(Lu¨neberg et al., 1995; Macosko et al., 1997). The initial
conformation of peptide II was the 1-ns conformation of
peptide I of the initial NVE run. This fact may allow the
NPT simulations to reach the equilibrated state in a relatively
short period. The latter is supported in that the average area
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per lipid is in good agreement with the experimental value.
Therefore, our simulation can be regarded as a reﬁnement of
the low-resolution experimental structure (i.e., the a-helical
conformation), but not as a simulation of the folding process
of the fusion peptide from a randomly chosen conformation.
Conformations of bilayer-bound peptide I and II
Our MD simulations revealed that both peptide I and II adopt
a kinked shape conformation that is different from the
previously proposed rod-like a-helical structure (Lu¨neberg
et al., 1995; Macosko et al., 1997). The kinked conformation
is consistent with the NMR structure of P20H7 (Han et al.,
2001). With respect to the low-energy NMR conformer of
P20H7 at pH 5, the mean root-mean-square deviation value
of all heavy atoms for peptide I is 3.03 6 0.30 A˚ and that
for peptide II is 5.046 0.17 A˚ (averaged over the period from
11 to 18 ns). These values indicate that the MD conformation
of the fusion peptide in a DMPC bilayer is similar to that
found in DPC micelles by NMR (Han et al., 2001).
FIGURE 2 Snapshots of the conformations of peptides I (A–D) and II (E–H) in NPT simulations. The hydrophobic pocket of peptide I (I) and peptide II (J) at
18 ns. The molecular drawing methods are the same as in Fig. 1. For clarity of the peptide, all water molecules and some lipids are removed.
Bilayer Conformation of Fusion Peptide 17
Biophysical Journal 87(1) 14–22
Experimental studies have shown that helical structures
are typical for membrane-bound fusion peptides (e.g., see
Chang et al., 2000; Gray et al., 1996; Han et al., 1999). To
characterize the secondary structure of peptide I and II, we
employed the DSSP program (http://www.cmbi.kun.nl/gv/
dssp/) and the do_dssp program from the GROMACS
package. Details about the deﬁnitions of the secondary
structure elements can be seen in Kabsch and Sander (1983).
The time evolutions of the secondary structure for peptide I
and II are presented in Fig. 4.
For peptide I, Fig. 4 A shows that the residues 2–12 form
a stable a-helix for t . ;2 ns, in good agreement with the
NMR structures of the fusion peptide at pH 5 and pH 7.4
(Han et al., 2001). The residues 13 and 14 are always in a coil
state, indicating that these two residues have no speciﬁc
hydrogen bonding with other residues. This feature is also
consistent with the experimental structure of the fusion
peptide P20H7. Residues 15–19 typically form a hydrogen
bonded turn. However, residues 16–19 occasionally adopt
a 310-helical conformation (shown in gray in Fig. 4 A).
Notably, a short 310-helix in this region is also present in the
NMR structure of P20H7 at pH 5. Peptide II harbors two
a-helical segments, residues 2–6 and 15–18 (Fig. 4 B). The
latter also occasionally forms a 310-helix for t . 11 ns.
Residues 10–13 are organized as a bend region with high
curvature.
The MD simulation reveals that the helical content (i.e.,
the number of residues in helical form) of both peptides is
;50%. This value is in agreement with experiments showing
that the helical content of the HA fusion peptide is in the
range from 25% to 50% (Chang et al., 2000; Gray et al.,
1996; Han et al., 1999).
Location and orientation of peptide side
chains in bilayers
Fig. 2 shows that the fusion peptide is located at the interface
between the headgroups and the hydrocarbon chains of the
DMPC bilayer. Fig. 5 summarizes the average z-positions of
the side chains for peptide I and II (averaged over the MD
trajectories from 11 to 18 ns). Here, the center of mass of
a side chain is taken to represent the z-position of the whole
residue (in case of Gly, the Ca atom is taken). The z
coordinates of the residues are found to be similar for peptide
I and II. Among all 20 amino acids, the maximal difference
of z coordinates for a given residue between peptide I and II
is;5 A˚ (i.e., those of Phe-3). As deduced from a comparison
of standard deviations, the ﬂuctuations of the z-position of
the residues in both peptides are similar (see the error bars in
Fig. 5). The polar residues Glu-11 and Asn-12 of the kinked
domain locate at the DMPC headgroup region (Fig. 2) and
have the largest distance from the central plane with a z
coordinate of 19 ; 20 A˚ (Fig. 5). The polar residues Glu-15
and Asp-19, which are oriented to the bulk water, have very
FIGURE 3 Time evolution of the area per lipid for system I (A) and
system II (B).
FIGURE 4 Time evolution of secondary structures of peptide I (A) and
II (B).
FIGURE 5 The average z-positions of peptide side chains in a DMPC
bilayer. The standard deviations are shown by error bars.
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similar z-positions. For peptide I, the residues most deeply
inserted into the bilayer are Leu-2 and Phe-3, which locate
about 5 A˚ above the center plane of the bilayer. For peptide
II, the most deeply immersed residue, Leu-2, has a similar
z-position (;5 A˚). Thus, the deepest residues of peptide I
and II are rather close to the central plane.
Recently, Zhou et al. (2000) suggested that the N-terminus
of HA fusion peptide (strain X31) is close to the aqueous
phase and is protonated at both neutral and low pH con-
ditions. Indeed, our simulations show that the N-terminus,
Gly-1, is oriented toward the polar headgroup region (see
Fig. 2). As shown in Fig. 5 for the protonated and the un-
protonated state, Gly-1 has an average z-position of ;10 A˚
in the DMPC bilayer. Therefore, consistent with the con-
clusion of Zhou et al. (2000), the MD simulations indicate
that the protonation state of the N-terminus is not a factor
determining the bilayer position of the N-terminal Gly-1.
A pocket-like hydrophobic region is formed on the side of
the peptide oriented to the central plane of the bilayer. In Fig.
2 (I and J), a more detailed illustration of the hydrophobic
pocket for peptide I and II at 18 ns is shown. The pocket is
formed by a cluster of eight hydrophobic residues: Leu-2,
Phe-3, Ala-5, Ile-6, Ala-7, Phe-9, Ile-10, and Trp-14 (in
blue). On the other side of the peptide, four hydrophilic
residues (i.e., Glu-11, Asn-12, Glu-15, and Asp-19 in red in
Fig. 2) project to the bulk water. Such an arrangement of
hydrophobic and hydrophilic residues is energetically
favorable, because the hydrophobic residues have a tendency
to partition into the hydrocarbon core of the bilayer, whereas
the hydrophilic residues have the opposite tendency orientat-
ing toward the water bulk. We surmise that the cluster of the
hydrophobic residues is an essential factor for the tight
binding of HA to the target membrane. A sequence com-
parison has shown that these hydrophobic residues are
conserved in 13 serotypes of HAs of inﬂuenza A viruses
(Nobusawa et al., 1991), also implying that such a cluster
region is crucial for the fusion activity of HA.
The above results show that the residues from Glu-11 to
Gly-20 of peptides form a stable amphipathic segment. Four
polar residues (Glu-11, Asn-12, Glu-15, and Asp-19) arrange
as a hydrophilic face, whereas three nonpolar residues (Trp-
14, Met-17, and Ile-18) form a hydrophobic face. Therefore,
the segment is located at the interface between the hydro-
carbon chains and polar headgroups of the DMPC bilayer. In
contrast, the segment from Gly-1 to Ile-10 is not amphipathic
because there is no polar residue in this segment. Compared
to the C-terminal segment from Glu-11 to Gly-20, this part
inserts more deeply into the hydrophobic core of the bilayer.
We suppose that this speciﬁc arrangement of hydrophobic
and hydrophilic residues is decisive for the formation of the
kinked conformation at the bilayer interface. Such a confor-
mation may be essential for membrane fusion. If so, the
replacement of a residue by an amino acid of different
properties (e.g., a hydrophobic residue by a hydrophilic
residue) should abolish fusion. It has been shown that fusion
activity was inhibited when Ile-10 (hydrophobic) was
replaced by Gly (nonhydrophobic). However, fusion activity
was maintained when Ile-10 was replaced by a hydrophobic
residue (Ala) (Cross et al., 2001).
Note that the chain length (14 carbon atoms) of the DMPC
lipids used in the simulations is shorter than that of lipids
usually occurring in biological membranes. Thus, one may
wonder whether the conformation of the fusion peptide in
biological membranes is somewhat different. To the best of
our knowledge, however, so far there is no evidence that the
bilayer-bound conformation of the fusion peptide changes
with the length of the hydrocarbon chain. Indeed, the
experimental results by Han et al. (2001) suggested that the
peptide conformation in the DPC micelles (chain length: 12
carbon atoms) is very similar to that in the bilayers com-
posed of 1-palmitoyl-2-oleoylphosphatidylcholine (POPC)/
1-palmitoyl-2-oleoylphosphatidylglycerol (POPG) (chain
length: 18 carbon atoms). The reason for this is that the
fusion peptide is located at the interface between hydrocar-
bon chains and headgroups, and only the hydrophobic side
chains immerse into the hydrophobic core. As we have al-
ready discussed, the major factor determining the bilayer-
bound conformation of the fusion peptide is the amphipathic
interface between headgroups and hydrocarbon chains, but
not solely the hydrocarbon core. Because the amphipathic
interface is essentially the same for phospholipid bilayers
with hydrocarbon chains of different lengths (at least for
those with the same headgroups), the conformation of the
fusion peptide is similar.
Perturbation of peptide-surrounding lipids
Experimental evidence has already been presented that the
insertion of the HA fusion peptide affects the organization of
the bilayer (see Introduction). We explored our approach to
address which alterations of the lipid phase are induced by
the insertion of the hydrophobic side chains of the fusion
peptide. We found that the average hydrophobic thickness of
the bilayer is affected by the fusion peptide.
To characterize the inﬂuence of the embedded fusion
peptide on the thickness of the bilayer, we investigated the
average position of the phospholipid carbonyl C atoms (see
Fig. 6 for two carbonyl C atoms in DMPC) and its dynamics.
These atoms were chosen since they deﬁne the interface
between polar headgroups and hydrophobic chains. Thus,
their z-position provides a reasonable measure for the
thickness of the hydrophobic region of the bilayer. In the
bulk phase of a pure DMPC bilayer, the average z-position of
carbonyl C atoms is ;14 A˚ from the central plane, with
ﬂuctuations in the range between 8 and 20 A˚ (Smondyrev
and Berkowitz, 1999; Zubrzycki et al., 2000). To examine
how the insertion of the peptide affects the z-position of the
carbonyl C atoms, we investigated in each leaﬂet two groups
of lipids that have the smallest (closest group) and the
greatest (farthest group) distance to the N-terminus of the
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peptide. To each group, 15 DMPC molecules were assigned
according to the distance between the C2 atom and the N
atom of the N-terminus (Gly-1) (see Fig. 6 for the C2 atom of
DMPC). The assignment was done for each frame of the MD
trajectories (t . 11 ns), and then the z-positions of the
carbonyl C-atoms of lipids in the assigned groups were taken
to calculate the density proﬁle (Fig. 6). For both systems, we
found that in the top leaﬂet harboring the peptide the average
z-positions of the carbonyl C atoms of the two groups are
very similar. However, the density proﬁle of the closest
group is broader with respect to the farthest group. This
indicates larger ﬂuctuations of lipids in the neighborhood of
the peptide. The latter was also observed for the bottom
leaﬂet, in particular for system II (Fig. 6 B).
Compared with the average z-positions of carbonyl C
atoms in pure DMPC bilayer, in the top leaﬂet of both
systems the carbonyl C atoms of both groups were found to
shift toward the central plane by ;2 A˚. In addition, we
observed a shift of the average z-position of the carbonyl C
atom of the closest group toward the central plane by;3 and
4 A˚ for systems I and II, respectively. As a consequence, the
local hydrophobic thickness near the N-terminus is ;4 A˚
smaller than that at the larger distance from the N-terminus.
Very likely, disordering of the arrangement of the hydro-
carbon chains of peptide-surrounding lipids causes the local
reduction of the bilayer thickness. This effect may become
even more pronounced by a concerted action of several
fusion peptides. Indeed, oligomerization of fusogenic
peptides has been suggested to promote local membrane
destabilization (Lau et al., 2004). Hristova et al. (2001) have
shown that dimeric melittin causes larger structural pertur-
bations of the bilayer in comparison with the monomer
(Hristova, et al., 2001).
CONCLUSIONS
In this study, we examined the conformation of the HA
fusion peptide (strain X31) in a DMPC bilayer by 18-ns NPT
simulations. In agreement with the structure of the fusion
peptide obtained from an NMR study (Han et al., 2001), the
simulations revealed that the bilayer-bound fusion peptide
is not a rigid, rod-like helix but adopts a kinked shape
conformation. The analysis of the secondary structure indi-
cated that the helical content of the fusion peptide was found
to be in the range of experimental data. The simulations
showed that the peptide is located at the amphipathic interface
between the polar headgroups and hydrocarbon chains. The
speciﬁc sequence and distribution of hydrophobic and hy-
drophilic residues along the HA fusion peptidemay be crucial
for the formation of the kinked conformation at the am-
phipathic interface.
We found that the local hydrophobic thickness of the
bilayer region close to the N-terminus of the peptide is
reduced in comparison with the hydrophobic thickness of the
bulk lipid phase, indicating that the lipids surrounding the
fusion peptide undergo a displacement along the axis normal
to the bilayer. The rearrangement of the peptide surrounding
lipids and the perturbation of the bilayer thickness might
reﬂect the destabilization of the membrane essential for
membrane fusion. Further studies will show how the fusion
activity of (mutant) fusion peptides correlates with the kinked
shape conformation of the peptide and the local rearrange-
ment of the lipid phase in the vicinity of the peptide.
Finally, we want to emphasize the limitations of the
molecular modeling approach. For example, because there is
no information available on the protonation state of several
residues of the fusion peptide, and no reliable method exists
to simulate a peptide-bilayer system at low pH conditions,
we cannot adapt exactly all experimental conditions of
interest. Also, these simulations did not allow to change the
numbers of DMPCs in the top and bottom leaﬂet that might
introduce artifacts (Dolan et al., 2002). In addition, it is still
very difﬁcult to simulate systems consisting of a larger
number of lipids and/or fusion peptides for periods as long as
tens or hundreds of nanoseconds due to limited computa-
tional capacity. Such studies may provide more fusion
FIGURE 6 Density proﬁles along the
bilayer normal for the carbonyl C atoms
of the lipids closest to and farthest from the
N-terminus. (A) System I. (B) System II.
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relevant details, e.g., how fusion peptides cause local bilayer
rearrangement at a larger length scale and the importance of
fusion peptide interactions for bilayer perturbation. However,
a huge number of examples including this study have proven
that theoretical studies such as MD simulation can provide
reasonable results complementing experimental data.
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